{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:38:36Z","timestamp":1787243916075,"version":"build-2736575974"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T00:00:00Z","timestamp":1652227200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R35 GM135179"],"award-info":[{"award-number":["R35 GM135179"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["2143826"],"award-info":[{"award-number":["2143826"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.redox.2022.102338","type":"journal-article","created":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T18:16:05Z","timestamp":1652724965000},"page":"102338","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Mitigation of doxorubicin-induced cardiotoxicity with an H2O2-Activated, H2S-Donating hybrid prodrug"],"prefix":"10.1016","volume":"53","author":[{"given":"Qiwei","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rama D.","family":"Yammani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Brown-Harding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Soto-Pantoja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0334-7328","authenticated-orcid":false,"given":"Leslie B.","family":"Poole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"John C.","family":"Lukesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.redox.2022.102338_bib1","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1124\/pr.56.2.6","article-title":"Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity","volume":"56","author":"Minotti","year":"2004","journal-title":"Pharmacol. Rev."},{"issue":"6","key":"10.1016\/j.redox.2022.102338_bib2","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/bit.260110607","article-title":"Adriamycin, 14-hydroxydaimomycin, a new antitumor antibiotic FromS. Peucetius Var.Caesius","volume":"11","author":"Arcamone","year":"1969","journal-title":"Biotechnol. Bioeng."},{"issue":"S5","key":"10.1016\/j.redox.2022.102338_bib3","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12918-017-0464-7","article-title":"A systematic analysis of FDA-approved anticancer drugs","volume":"11","author":"Sun","year":"2017","journal-title":"BMC Syst. Biol."},{"key":"10.1016\/j.redox.2022.102338_bib4","doi-asserted-by":"crossref","first-page":"119527","DOI":"10.1016\/j.lfs.2021.119527","article-title":"A comprehensive review on time-tested anticancer drug doxorubicin","volume":"278","author":"Sritharan","year":"2021","journal-title":"Life Sci."},{"issue":"7","key":"10.1016\/j.redox.2022.102338_bib5","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0006-2952(98)00307-4","article-title":"Critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin","volume":"57","author":"Gewirtz","year":"1999","journal-title":"Biochem. Pharmacol."},{"issue":"13","key":"10.1016\/j.redox.2022.102338_bib6","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1056\/NEJM199809243391307","article-title":"Doxorubicin-induced cardiomyopathy","volume":"339","author":"Singal","year":"1998","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.redox.2022.102338_bib7","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1002\/1097-0142(19850615)55:12<2761::AID-CNCR2820551206>3.0.CO;2-P","article-title":"Early and delayed clinical cardiotoxicity of doxorubicin","volume":"55","author":"Buzdar","year":"1985","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.redox.2022.102338_bib8","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1002\/cncr.11407","article-title":"Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials","volume":"97","author":"Swain","year":"2003","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.redox.2022.102338_bib9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10565-006-0140-y","article-title":"Adriamycin-induced oxidative mitochondrial cardiotoxicity","volume":"23","author":"Berthiaume","year":"2007","journal-title":"Cell Biol. Toxicol."},{"issue":"6","key":"10.1016\/j.redox.2022.102338_bib10","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.fct.2010.04.007","article-title":"New advances in molecular mechanisms and the prevention of adriamycin toxicity by antioxidant nutrients","volume":"48","author":"Granados-Principal","year":"2010","journal-title":"Food Chem. Toxicol."},{"issue":"6","key":"10.1016\/j.redox.2022.102338_bib11","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.yjmcc.2012.03.006","article-title":"Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies","volume":"52","author":"Octavia","year":"2012","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.redox.2022.102338_bib12","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.31788\/RJC.2020.1325603","article-title":"ANTI-CANCER drug doxorubicin induced cardiotoxicity: understanding the mechanisms involved IN ROS generation resulting IN mitochondrial dysfunction","volume":"13","author":"Upadhayay","year":"2020","journal-title":"Rasayan J. Chem."},{"key":"10.1016\/j.redox.2022.102338_bib13","doi-asserted-by":"crossref","first-page":"111708","DOI":"10.1016\/j.biopha.2021.111708","article-title":"Doxorubicin-induced cardiotoxicity: an update on the molecular mechanism and novel therapeutic strategies for effective management","volume":"139","author":"Rawat","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"7","key":"10.1016\/j.redox.2022.102338_bib14","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1016\/S0021-9258(17)35747-2","article-title":"Redox cycling of anthracyclines by cardiac mitochondria. II. Formation of superoxide anion, hydrogen peroxide, and hydroxyl radical","volume":"261","author":"Doroshow","year":"1986","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.redox.2022.102338_bib15","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1161\/CIRCRESAHA.119.314681","article-title":"Mitochondrial determinants of doxorubicin-induced cardiomyopathy","volume":"126","author":"Wallace","year":"2020","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.redox.2022.102338_bib16","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1172\/JCI109642","article-title":"Enzymatic defenses of the mouse heart against reactive oxygen metabolites","volume":"65","author":"Doroshow","year":"1980","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.redox.2022.102338_bib17","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0300-483X(02)00383-9","article-title":"Antioxidant nutrients and adriamycin toxicity","volume":"180","author":"Quiles","year":"2002","journal-title":"Toxicology"},{"issue":"1","key":"10.1016\/j.redox.2022.102338_bib18","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0304-3835(98)00306-1","article-title":"Antioxidants protect against reactive oxygen species associated with adriamycin-treated cardiomyocytes","volume":"136","author":"DeAtley","year":"1999","journal-title":"Cancer Lett."},{"issue":"2","key":"10.1016\/j.redox.2022.102338_bib19","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s12012-007-0019-z","article-title":"Novel antioxidants in anthracycline cardiotoxicity","volume":"7","author":"Hideg","year":"2007","journal-title":"Cardiovasc. Toxicol."},{"issue":"19","key":"10.1016\/j.redox.2022.102338_bib20","doi-asserted-by":"crossref","first-page":"5307","DOI":"10.1016\/j.bmcl.2013.07.070","article-title":"Doxorubicin-antioxidant Co-drugs","volume":"23","author":"Chegaev","year":"2013","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"10","key":"10.1016\/j.redox.2022.102338_bib21","doi-asserted-by":"crossref","first-page":"4881","DOI":"10.1021\/acs.jmedchem.6b00184","article-title":"2 S-donating doxorubicins may overcome cardiotoxicity and multidrug resistance","volume":"59","author":"Chegaev","year":"2016","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.redox.2022.102338_bib22","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1021\/tx2005234","article-title":"Small molecule signaling agents: the integrated chemistry and biochemistry of nitrogen oxides, oxides of carbon, dioxygen, hydrogen sulfide, and their derived species","volume":"25","author":"Fukuto","year":"2012","journal-title":"Chem. Res. Toxicol."},{"issue":"1","key":"10.1016\/j.redox.2022.102338_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/ars.2017.7058","article-title":"A review of hydrogen sulfide synthesis, metabolism, and measurement: is modulation of hydrogen sulfide a novel therapeutic for cancer?","volume":"31","author":"Cao","year":"2019","journal-title":"Antioxidants Redox Signal."},{"issue":"1","key":"10.1016\/j.redox.2022.102338_bib24","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00726-010-0510-x","article-title":"Hydrogen sulfide: its production, release and functions","volume":"41","author":"Kimura","year":"2011","journal-title":"Amino Acids"},{"issue":"9","key":"10.1016\/j.redox.2022.102338_bib25","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1080\/15216540500217875","article-title":"Hydrogen sulfide as a vasodilator","volume":"57","author":"Bhatia","year":"2005","journal-title":"IUBMB Life Int. Union Biochem. Mol. Biol. Life"},{"key":"10.1016\/j.redox.2022.102338_bib26","article-title":"The role of hydrogen sulphide in blood pressure regulation","volume":"S273\u2013S289","author":"Cacanyiova","year":"2016","journal-title":"Physiol. Res."},{"issue":"3","key":"10.1016\/j.redox.2022.102338_bib27","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1021\/acs.chemrev.7b00205","article-title":"Chemical biology of H 2 S signaling through persulfidation","volume":"118","author":"Filipovic","year":"2018","journal-title":"Chem. Rev."},{"issue":"21","key":"10.1016\/j.redox.2022.102338_bib28","doi-asserted-by":"crossref","first-page":"6008","DOI":"10.1093\/emboj\/20.21.6008","article-title":"The vasorelaxant effect of H2S as a novel endogenous gaseous KATP channel opener","volume":"20","author":"Zhao","year":"2001","journal-title":"EMBO J."},{"issue":"39","key":"10.1016\/j.redox.2022.102338_bib29","doi-asserted-by":"crossref","first-page":"15560","DOI":"10.1073\/pnas.0705891104","article-title":"Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function","volume":"104","author":"Elrod","year":"2007","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"issue":"1","key":"10.1016\/j.redox.2022.102338_bib30","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00395-005-0569-9","article-title":"Exogenous hydrogen sulfide (H2S) protects against regional myocardial ischemia\u2013reperfusion injury: evidence for a role of KATP channels","volume":"101","author":"Johansen","year":"2006","journal-title":"Basic Res. Cardiol."},{"issue":"6","key":"10.1016\/j.redox.2022.102338_bib31","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1111\/bph.12869","article-title":"Hydrogen sulfide: physiological properties and therapeutic potential in ischaemia: properties of H 2 S in ischaemia","volume":"172","author":"Bos","year":"2015","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.redox.2022.102338_bib32","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1042\/BJ20082421","article-title":"Hydrogen sulfide destroys lipid hydroperoxides in oxidized LDL","volume":"420","author":"Muellner","year":"2009","journal-title":"Biochem. J."},{"key":"10.1016\/j.redox.2022.102338_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/9152732","article-title":"Reactive oxygen species: a key hallmark of cardiovascular disease","volume":"2016","author":"Panth","year":"2016","journal-title":"Adv. Met. Med."},{"issue":"5","key":"10.1016\/j.redox.2022.102338_bib34","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.freeradbiomed.2011.05.004","article-title":"Reactive oxygen species in cardiovascular disease","volume":"51","author":"Sugamura","year":"2011","journal-title":"Free Radic. Biol. Med."},{"issue":"9","key":"10.1016\/j.redox.2022.102338_bib35","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1039\/C9MD00169G","article-title":"Prodrug strategies for targeted therapy triggered by reactive oxygen species","volume":"10","author":"Peir\u00f3 Cadah\u00eda","year":"2019","journal-title":"MedChemComm"},{"issue":"5","key":"10.1016\/j.redox.2022.102338_bib36","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3109\/10715761003667554","article-title":"Reactive oxygen species in cancer","volume":"44","author":"Liou","year":"2010","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.redox.2022.102338_bib37","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ejmech.2016.03.063","article-title":"10-Boronic acid substituted camptothecin as prodrug of SN-38","volume":"116","author":"Wang","year":"2016","journal-title":"Eur. J. Med. Chem."},{"issue":"48","key":"10.1016\/j.redox.2022.102338_bib38","doi-asserted-by":"crossref","first-page":"19278","DOI":"10.1021\/ja2073824","article-title":"Hydrogen peroxide inducible DNA cross-linking agents: targeted anticancer prodrugs","volume":"133","author":"Kuang","year":"2011","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"10.1016\/j.redox.2022.102338_bib39","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1021\/acsmedchemlett.8b00539","article-title":"Enhanced tumor selectivity of 5-fluorouracil using a reactive oxygen species-activated prodrug approach","volume":"10","author":"Ai","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.redox.2022.102338_bib40","doi-asserted-by":"crossref","first-page":"103158","DOI":"10.1016\/j.bioorg.2019.103158","article-title":"Arylboronate prodrugs of doxorubicin as promising chemotherapy for pancreatic cancer","volume":"91","author":"Skarbek","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"23","key":"10.1016\/j.redox.2022.102338_bib41","doi-asserted-by":"crossref","first-page":"7256","DOI":"10.1021\/jacs.6b03780","article-title":"Self-immolative thiocarbamates provide access to triggered H 2 S donors and analyte replacement fluorescent probes","volume":"138","author":"Steiger","year":"2016","journal-title":"J. Am. Chem. Soc."},{"issue":"47","key":"10.1016\/j.redox.2022.102338_bib42","doi-asserted-by":"crossref","first-page":"14638","DOI":"10.1002\/anie.201608052","article-title":"Hydrogen sulfide donors activated by reactive oxygen species","volume":"55","author":"Zhao","year":"2016","journal-title":"Angew. Chem. Int. Ed."},{"issue":"9","key":"10.1016\/j.redox.2022.102338_bib43","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1021\/ar200126t","article-title":"Boronate oxidation as a bioorthogonal reaction approach for studying the chemistry of hydrogen peroxide in living systems","volume":"44","author":"Lippert","year":"2011","journal-title":"Acc. Chem. Res."},{"issue":"9","key":"10.1016\/j.redox.2022.102338_bib44","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1021\/acs.accounts.9b00315","article-title":"Development and application of carbonyl sulfide-based donors for H2S delivery","volume":"52","author":"Levinn","year":"2019","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.redox.2022.102338_bib45","doi-asserted-by":"crossref","first-page":"16365","DOI":"10.1021\/jacs.7b09527","article-title":"Kinetic insights into hydrogen sulfide delivery from caged-carbonyl sulfide isomeric donor platforms","volume":"139","author":"Zhao","year":"2017","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.redox.2022.102338_bib46","first-page":"168","article-title":"ROS-responsive, self-immolative and self-reporting hydrogen sulfide donor with multiple biological activities for the treatment of myocardial infarction","volume":"9","author":"Yao","year":"2022","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.redox.2022.102338_bib47","doi-asserted-by":"crossref","first-page":"7690","DOI":"10.1039\/C9SC02323B","article-title":"Reactive oxygen species-triggered off-on fluorescence donor for imaging hydrogen sulfide delivery in living cells","volume":"10","author":"Hu","year":"2019","journal-title":"Chem. Sci."},{"issue":"13","key":"10.1016\/j.redox.2022.102338_bib48","doi-asserted-by":"crossref","DOI":"10.1021\/acs.orglett.8b01356","article-title":"Reactive oxygen species-triggered tunable hydrogen sulfide release","volume":"20","author":"Chauhan","year":"2018","journal-title":"Org. Lett."},{"key":"10.1016\/j.redox.2022.102338_bib49","doi-asserted-by":"crossref","first-page":"152944","DOI":"10.1016\/j.tetlet.2021.152944","article-title":"Illuminating and alleviating cellular oxidative stress with an ROS-activated, H2S-donating theranostic","volume":"69","author":"Zhu","year":"2021","journal-title":"Tetrahedron Lett."},{"issue":"22","key":"10.1016\/j.redox.2022.102338_bib50","doi-asserted-by":"crossref","first-page":"6108","DOI":"10.1039\/C6CS00212A","article-title":"A practical guide to working with H 2 S at the interface of chemistry and biology","volume":"45","author":"Hartle","year":"2016","journal-title":"Chem. Soc. Rev."},{"issue":"1\u20133","key":"10.1016\/j.redox.2022.102338_bib51","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.tox.2007.09.009","article-title":"Prevention of hydrogen sulfide (H2S)-Induced mouse lethality and cytotoxicity by hydroxocobalamin (vitamin B12a)","volume":"242","author":"Truong","year":"2007","journal-title":"Toxicology"},{"issue":"3","key":"10.1016\/j.redox.2022.102338_bib52","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3390\/antiox10030349","article-title":"Nrf2 signaling pathway in chemoprotection and doxorubicin resistance: potential application in drug discovery","volume":"10","author":"Mirzaei","year":"2021","journal-title":"Antioxid. Basel Switz."},{"issue":"6","key":"10.1016\/j.redox.2022.102338_bib53","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s12012-020-09581-7","article-title":"Disruption of the Keap1\/nrf2-antioxidant response system After chronic doxorubicin exposure in vivo","volume":"20","author":"Nordgren","year":"2020","journal-title":"Cardiovasc. Toxicol."},{"issue":"6","key":"10.1016\/j.redox.2022.102338_bib54","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.3390\/ijms22063269","article-title":"Cardiac protective effect of Kirenol against doxorubicin-induced cardiac hypertrophy in H9c2 cells through Nrf2 signaling via PI3K\/AKT pathways","volume":"22","author":"Alzahrani","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.redox.2022.102338_bib55","doi-asserted-by":"crossref","first-page":"107533","DOI":"10.1016\/j.intimp.2021.107533","article-title":"Pinocembrin inhibited cardiomyocyte pyroptosis against doxorubicin-induced cardiac dysfunction via regulating nrf2\/sirt3 signaling pathway","volume":"95","author":"Gu","year":"2021","journal-title":"Int. Immunopharm."}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231722001100?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231722001100?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T06:25:29Z","timestamp":1761978329000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213231722001100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":55,"alternative-id":["S2213231722001100"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2022.102338","relation":{},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mitigation of doxorubicin-induced cardiotoxicity with an H2O2-Activated, H2S-Donating hybrid prodrug","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2022.102338","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102338"}}